Status:
UNKNOWN
Anti-mullerian Hormone,Testesterone,Esrtadiol,Testesterone/Esrtadiol Ratio as Predictive Values for TESA and TESE Outcome in Non Obstructive Azoospermia
Lead Sponsor:
Assiut University
Conditions:
Non-obstructive Azoospermia
Eligibility:
MALE
20-50 years
Brief Summary
\*Evaluate the predictive value of AMH, Testosterone,Estradiol,Testosterone Estradiol ratio for TESA and TESE outcome in non obstructive azoospermic patients.
Detailed Description
* The relevance of male infertility has progressively grown , with significant medical, psychological, and socio-economic implications. .. With no sperm found at multiple semen analyses, non-obstructi...
Eligibility Criteria
Inclusion
- a clinical diagnosis of NOA associated with primary couple's infertility;
- age from 20 to 50 years old
- freedom from any known systemic diseases affecting the previous hormonal levels such as liver cirrhosis .
- hormonal therapy for at least two weeks prior to the surgery
Exclusion
- obstructive azoospermia
- congenital bilateral absent vas
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04308486
Start Date
December 1 2020
End Date
February 1 2022
Last Update
March 16 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.